Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Blumenthal

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
Neurology|October 21, 2005
Capecitabine-induced multifocal leukoencephalopathy: a report of five casesA Videnovic, I Semenov, R Chua-Adajar, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 20, 2012
The impact of enrollment in clinical trials on survival of patients with glioblastomaTal Shahar, Erez Nossek, David M Steinberg, et al.
Neuro-Oncology|September 10, 2008
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131Michael A Vogelbaum, Brian Berkey, David Peereboom, et al.
Journal of Neuro-Oncology|January 15, 2018
Neurologic complications of immune checkpoint inhibitorsAvi Fellner, Chen Makranz, Michal Lotem, et al.
International Journal of Clinical Oncology|November 20, 2014
A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001Deborah T Blumenthal, Cathryn Rankin, Keith J Stelzer, et al.
Cancer|June 4, 2008
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trialDeborah T Blumenthal, Cathryn Rankin, Harmon J Eyre, et al.
Journal of Neuro-Oncology|August 18, 2016
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patientsDeborah T Blumenthal, Addie Dvir, Alexander Lossos, et al.
Plos One|December 5, 2012
Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumorsDafna Ben Bashat, Moran Artzi, Haim Ben Ami, et al.
AJNR. American Journal of Neuroradiology|July 9, 2016
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade GliomasD Daniels, D Guez, D Last, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525Wenyin Shi, Molly Scannell Bryan, Mark R Gilbert, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
Neurology|October 21, 2005
Capecitabine-induced multifocal leukoencephalopathy: a report of five casesA Videnovic, I Semenov, R Chua-Adajar, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 20, 2012
The impact of enrollment in clinical trials on survival of patients with glioblastomaTal Shahar, Erez Nossek, David M Steinberg, et al.
Neuro-Oncology|September 10, 2008
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131Michael A Vogelbaum, Brian Berkey, David Peereboom, et al.
Journal of Neuro-Oncology|January 15, 2018
Neurologic complications of immune checkpoint inhibitorsAvi Fellner, Chen Makranz, Michal Lotem, et al.
International Journal of Clinical Oncology|November 20, 2014
A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001Deborah T Blumenthal, Cathryn Rankin, Keith J Stelzer, et al.
Cancer|June 4, 2008
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trialDeborah T Blumenthal, Cathryn Rankin, Harmon J Eyre, et al.
Journal of Neuro-Oncology|August 18, 2016
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patientsDeborah T Blumenthal, Addie Dvir, Alexander Lossos, et al.
Plos One|December 5, 2012
Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumorsDafna Ben Bashat, Moran Artzi, Haim Ben Ami, et al.
AJNR. American Journal of Neuroradiology|July 9, 2016
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade GliomasD Daniels, D Guez, D Last, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525Wenyin Shi, Molly Scannell Bryan, Mark R Gilbert, et al.
Pageof 23